SHANK3 and premenstrual tension: Here, we describe the clinical and molecular data of one of the largest cohorts of patients with confirmed genetic diagnosis of PMS, most of them with microdeletions (189/210, 90%) and 21 with SHANK3 sequence variants (10%).